Gestational trophoblastic neoplasia
Prepared with OnCo (onco.cc/prep/gestational-trophoblastic/). Orientation, not medical advice; your team knows your case.
My details
What I know, what is unclear, changes to discuss
Saved in this browserMy questions
17 on the sheet- 1.What is my exact diagnosis, stage, and grade, and which tests established them?
- 2.Which biomarkers have been tested on my tumour (for example Serum hCG, FIGO 2000 prognostic score, Hyperglycosylated hCG / hCG-free beta, Genotyping to confirm gestational origin, PD-L1), and what were the results?
- 3.Which subtype is my cancer, and does that change the recommended treatment?
- 4.Is germline (inherited) genetic testing recommended for me or my family?
- 5.For my situation (low-risk gtn (figo score 0-6)), which of the standard options do you recommend and why?
- 6.Am I a candidate for Methotrexate, Dactinomycin (actinomycin D), and what side effects should I expect?
- 7.For my situation (high-risk gtn (score ≥7)), which of the standard options do you recommend and why?
- 8.Am I a candidate for Etoposide, Methotrexate, Dactinomycin (actinomycin D) or related drugs, and what side effects should I expect?
- 9.For my situation (chemotherapy-resistant gtn), which of the standard options do you recommend and why?
- 10.Am I a candidate for Pembrolizumab, Avelumab, and what side effects should I expect?
- 11.For my situation (pstt / ett), which of the standard options do you recommend and why?
- 12.Am I a candidate for Cisplatin, Etoposide, and what side effects should I expect?
- 13.Are there clinical trials I could join, for example of Pembrolizumab, Avelumab?
- 14.Would a second opinion at a high-volume centre change anything, and can you help arrange it?
- 15.What supportive care (symptom control, nutrition, exercise, mental health, financial help) is available from the start?
- 16.I read that “Late diagnosis where hCG surveillance after molar pregnancy is absent (much of the world)”. How does that affect my plan?
- 17.I read that “Fertility and psychological burden of a pregnancy-related cancer”. How does that affect my plan?
The words I may hear
- Cancer during pregnancy: About 1 in 1,000 pregnancies is complicated by cancer, most often breast, cervical, lymphoma, melanoma or leukaemia.
- Rare cancers: Rare cancers are those with fewer than about 6 new cases per 100,000 people per year.
Tests and results to bring
Biomarker results to ask for: Serum hCG (diagnosis, staging, response, surveillance), FIGO 2000 prognostic score (low ≤6, high ≥7, ultra-high ≥13), Hyperglycosylated hCG / hCG-free beta (PSTT), Genotyping to confirm gestational origin, PD-L1 (expressed in nearly all GTN).
Scans and tests linked to this cancer: AFP, hCG and LDH in germ cell tumours (IGCCCG risk groups), Serum tumour markers: proper use and misuse, Ultrasound.
Bring copies of scan reports, pathology and blood results, and a list of every medicine and supplement.
The treatments I may be offered
- High-risk GTN (score ≥7): EMA-CO (etoposide, methotrexate, actinomycin D / cyclophosphamide, vincristine); induction low-dose EP for ultra-high-risk; EP-EMA or TP/TE at relapse; surgery for resistant foci. (Etoposide, Methotrexate, Dactinomycin (actinomycin D), Cyclophosphamide, Vincristine, Cisplatin)
- Low-risk GTN (FIGO score 0-6): Single-agent methotrexate (8-day regimen) or pulsed actinomycin D; switch agent on resistance; consolidate 3 cycles after hCG normalisation. (Methotrexate, Dactinomycin (actinomycin D))
- PSTT / ETT: Hysterectomy; platinum-etoposide chemotherapy if metastatic or >4 years from antecedent pregnancy. (Cisplatin, Etoposide)
- Chemotherapy-resistant GTN: PD-1/PD-L1 blockade (pembrolizumab, avelumab), high-dose chemotherapy with stem-cell rescue in selected cases, hysterectomy or metastasectomy. (Pembrolizumab, Avelumab, Autologous stem cell transplant (high-dose therapy))
From the standard of care recorded for this cancer; which apply depends on your stage and biomarkers. Ask which the team recommends and why.